ARTICLE | Clinical News
JZP-258: Ph III started
March 23, 2017 8:51 PM UTC
Jazz began a double-blind, placebo-controlled, international Phase III trial to evaluate JZP-258 in about 130 patients....
BCIQ Company Profiles
BCIQ Target Profiles
Jazz began a double-blind, placebo-controlled, international Phase III trial to evaluate JZP-258 in about 130 patients....
BCIQ Company Profiles
BCIQ Target Profiles